Version history

{
  "session_id": "sess_SDA-2026-04-15-gap-pubmed-20260411-075338-35f913fb_20260416-034701",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "critique",
  "content": "\n\n# Critical Evaluation: Mechanistic Hypotheses for HDAC9 in Alzheimer's Disease\n\n## Hypothesis 1: TFEB-Lyzed Autophagy Upregulation\n\n### Strongest Specific Weakness\n**Mechanistic paradox**: The proposed mechanism requires HDAC9 to directly deacetylate and activate TFEB, but Class IIa HDACs (HDAC4, 5, 7, 9) possess remarkably weak intrinsic deacetylase activity—their \"HDAC\" domain has a Histidine substitution at the active site that ablates catalytic function (PMID: **15644326**, **18566587**). Class IIa HDACs function primarily as scaffolds that recruit Class I HDACs (especially HDAC3) rather than as direct deacetylases. If HDAC9 cannot deacetylate TFEB directly, the proposed mechanism collapses at step one.\n\n### Counter-Evidence and Complications\nTFEB nuclear translocation is governed predominantly by **phosphorylation** (mTORC1-dependent) and 14-3-3 binding, not acetylation (PMID: **22437836**, **20679226**). Lysosomal biogenesis genes are activated by nutritional status (fasting induces nuclear TFEB), not by Class IIa HDAC activity. Furthermore, HDAC inhibition *enhances* autophagy in many contexts—a finding difficult to reconcile with HDAC9 activating the same pathway (PMID: **20600726**).\n\n### Pointed Question\nWhat is the direct molecular evidence that HDAC9 acts at the *TFEB* locus or deacetylates TFEB protein, as opposed to HDAC9 modulating autophagy through indirect transcriptional programs (e.g., as part of a stress-response gene network)? If TFEB target genes are upregulated but TFEB itself shows no change in nuclear localization, the hypothesis must specify an alternative effector.\n\n### Confidence Rating: **MODERATE → WEAK**\nThe endpoint (enhanced autophagy-lysosomal clearance) is plausible and the cited literature supports TFEB as a therapeutic target for amyloid clearance. However, the *specific mechanism* connecting HDAC9 to TFEB activation lacks biochemical plausibility given Class IIa HDAC enzymology. The hypothesis requires either (a) revision to invoke HDAC9 recruiting HDAC3 to deacetylate relevant substrates, or (b) identification of HDAC9",
  "tokens_used": "523"
}